Alfoo 10mg Tablet
$25.00 – $65.00
$25.00 – $65.00
|Variation||Price||Price/Unit||Add To Cart|
|30 Tablet/s||$25.00 (0.83/unit)||0.83|
|60 Tablet/s||$46.00 (0.77/unit)||0.77|
|90 Tablet/s||$65.00 (0.72/unit)||0.72|
|Country of Origin||
Treatment of Benign prostatic hyperplasia
30 tablets in 1 strip
Dr Reddy's Laboratories Ltd
Alfoo 10mg Tablet PR is an alpha adrenergic antagonist that is used in the treatment of benign prostatic hyperplasia. It helps to relieve symptoms like difficulty in passing urine. However, it does not decrease the size of the prostate.
Alfoo 10mg Tablet PR is advised to take it in a dose and duration as per prescription. It should be taken with food, but take at the same time regularly. Swallow the medicine as a whole without crushing or chewing it. You should not stop taking the medicine without consulting the doctor as it may lead to the worsening of your symptoms. The course of the treatment should be completed for better efficacy of the medicine.
Some common side effects of this medicine are upper respiratory tract infection, headache, and tiredness. It may also lead to blurry vision or dizziness, so it is advised to avoid driving while on the medication. If any of the side effects persist or bother you, you must consult the doctor without delay.
Simple lifestyle changes can help you manage your symptoms better. Try to urinate as soon as you feel the urge, however, never strain or push to empty your bladder. You should avoid drinking caffeinated or alcoholic drinks at night and a few hours before going to bed or going out.
Before receiving the treatment, inform your doctor if you are on any medication for any other health condition. If you have to undergo eye surgery due to cataracts or glaucoma then inform your eye doctor about the usage of this medicine. Patients with liver or kidney disease must be cautious while receiving the prescription, and they must receive regular follow-ups as per the doctor’s advice.
- Treatment of Benign prostatic hyperplasia
Common side effects of Alfoo
- Upper respiratory tract infection